TW217986B - Compositions for the treatment of infection and disease caused by HBV - Google Patents

Compositions for the treatment of infection and disease caused by HBV

Info

Publication number
TW217986B
TW217986B TW81102630A TW81102630A TW217986B TW 217986 B TW217986 B TW 217986B TW 81102630 A TW81102630 A TW 81102630A TW 81102630 A TW81102630 A TW 81102630A TW 217986 B TW217986 B TW 217986B
Authority
TW
Taiwan
Prior art keywords
hbv
infection
treatment
disease caused
compositions
Prior art date
Application number
TW81102630A
Other languages
Chinese (zh)
Inventor
Dennis W Adair
Kenneth A Smiles
Dannie King
Original Assignee
Oclassen Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oclassen Pharma Inc filed Critical Oclassen Pharma Inc
Application granted granted Critical
Publication of TW217986B publication Critical patent/TW217986B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to pharmaceutical compositions useful for the treatment of subjects suffering from an infection or disease caused by the hepatitis B virus (HBV). In particular, it has been discovered that the administration of low dosage amounts of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) to humans chronically infected with HBV is effective to reduce drastically circulating markers associated with HBV. The present invention is also directed to methods of the preparation of pharmaceutical antiviral compositions.
TW81102630A 1992-04-06 1992-04-07 Compositions for the treatment of infection and disease caused by HBV TW217986B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86389092A 1992-04-06 1992-04-06

Publications (1)

Publication Number Publication Date
TW217986B true TW217986B (en) 1993-12-21

Family

ID=25342034

Family Applications (1)

Application Number Title Priority Date Filing Date
TW81102630A TW217986B (en) 1992-04-06 1992-04-07 Compositions for the treatment of infection and disease caused by HBV

Country Status (3)

Country Link
LT (1) LTIP472A (en)
TW (1) TW217986B (en)
ZA (1) ZA932271B (en)

Also Published As

Publication number Publication date
ZA932271B (en) 1993-10-18
LTIP472A (en) 1994-10-25

Similar Documents

Publication Publication Date Title
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
CA2293470A1 (en) Benzimidazole derivatives
EP0270317A3 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
MY130035A (en) Antiviral compounds
JPS6425A (en) Medicinal composition for treating hiv infection containing dsrna and reverse transcriptase inhibitor
WO2003063771A3 (en) N4-acylcytosine nucleosides for treatment of viral iinfections
CA2033044A1 (en) 6-substituted purine carbocyclic nucleosides
ATE157257T1 (en) ENHANCEMENT OF SUPPRESSIVE REGULATION OF AUTOIMMUNE DISEASES BY ORAL OR ENTERAL ADMINISTRATION OF AUTOANTIGENS
CA2271622A1 (en) Antiviral agents from plant extracts and use for treatment of viral infections
WO1998004290A3 (en) Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
ES2105923A1 (en) Compositions containing 5-iodouracil derivatives for the treatment of hepatitis B infections.
MX9805441A (en) Therapeutic compounds.
MX9701273A (en) 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent.
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
ATE79034T1 (en) TREATMENT OF VIRUS DISEASES.
EA199900345A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LAMIVUDIN AND ZIDOVUDIN
TW217986B (en) Compositions for the treatment of infection and disease caused by HBV
KR910005886A (en) Stabilized Leukocyte Interferon
MY111746A (en) Therapeutic nucleosides.
DE3462891D1 (en) New pyrimidine derivatives endowed with antiviral activity
MY101495A (en) Treatment of diseases caused by viruses
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections